Renal Cell Carcinoma
Renal cell carcinoma is kidney cancer that affects the lining of the kidney tubules. The initial stages of the cancer are asymptomatic and this makes early management of the disease difficult.
Brand Names and Generic Names of Drugs for Treatment of Renal Cell Carcinoma
Aldesleukin
Aldesleukin is a cancer-treating drug prescribed for treating advanced kidney cancer or renal cell carcinoma and metastatic skin cancer that has spread to other parts of the body.
Everolimus
Everolimus is a kinase inhibitor, prescribed for kidney cancer, pancreatic cancer, brain tumor(astrocytoma), hormone-receptor–positive breast cancer in postmenopausal women and prevents organ rejection in kidney therapy.
Nivolumab
Nivolumab is a monoclonal antibody and a PD-1 inhibitor (programmed death receptor inhibitor) which is prescribed for cancer treatment.
Sorafenib
Sorafenib is a kinase inhibitor, prescribed for renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer).
Sunitinib
Sunitinib is a multikinase inhibitor, prescribed for gastrointestinal stromal tumor or renal cell carcinoma (RCC), and pancreatic neuroendocrine tumors (pNET).
Advertisement
